How many subsidiaries does NovoCure Ltd file with the SEC?

19, listed in its most recent exhibit 21. They are incorporated across 17 jurisdictions, led by Austria, Belgium, Canada. 2 of them sit in offshore financial centres. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.

Is NovoCure Ltd financially healthy?

NovoCure Ltd scores 3 out of 9 on the Piotroski F-score. Its Altman Z-score puts it in the distress zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.

Who are the largest institutional holders of NovoCure Ltd?

Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are FMR LLC (adding), BlackRock, Inc. (adding), MORGAN STANLEY (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

NovoCure Ltd (NVCR)

Nasdaq · Common Stock · Surgical & Medical Instruments & Apparatus

One email a week from me: what it filed, which 13F holders added or cut, where its scores stand. Free.

Corporate structure

19 entities across 17 jurisdictions, 2 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.

Which other public companies file entities in the same places:

Luxembourg2 Delaware2 Austria1 Belgium1 Canada1 Denmark1 Israel1 France1 Germany1 Italy1 Japan1 Netherlands1

Subsidiaries of NovoCure Ltd as disclosed in its SEC filing
Entity	Jurisdiction	Note
Novocure Austria GmbH	Austria
Novocure Belgium S.r.l.	Belgium
Novocure Canada, Inc.	Canada
Novocure Capital S.à.r.l.	Luxembourg	offshore centre
Novocure Denmark ApS	Denmark
NovoCure (Israel) Ltd.	Israel
Novocure France SAS	France
NovoCure GmbH	Germany
Novocure Inc.	Delaware
Novocure Italy S.r.L.	Italy
Novocure K.K.	Japan

Financial health

Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.

Piotroski F-score

3 / 9

FAILReturn on assets positiveROA -16.9%
FAILOperating cash flow positiveOCF -49M
FAILReturn on assets improving-13.6% → -16.9%
PASSCash flow exceeds earningsOCF -49M vs NI -136M
FAILLong-term debt ratio falling7.8% → 24.2% of assets
PASSCurrent ratio improving1.46 → 2.90
FAILNo share dilution108M → 111M shares
FAILGross margin improving77.3% → 74.5%
PASSAsset turnover improving0.49× → 0.81×

Altman Z-score

0.77distress

Bankruptcy-risk screen combining working capital, retained earnings, operating income, market value against liabilities, and asset turnover. Above 2.99 is the safe zone; below 1.81 is distress.

Six-year record

Year	Revenue	Net income	Free cash flow	Gross margin	Shares
FY2020	$494.4M	$19.8M	$84.2M	78.5%	108,877,648
FY2021	$535.0M	−$58.4M	$58.6M	78.5%	103,433,274
FY2022	$537.8M	−$92.5M	$9.4M	78.6%	104,660,476
FY2023	$509.3M	−$207.0M	−$100.4M	74.8%	106,391,178
FY2024	$605.2M	−$168.6M	−$69.2M	77.3%	107,834,368

Ownership flow

13 institutions tracked — 10 added, 3 reduced.

Institutional holders of NovoCure Ltd and their share-count change
Manager	Kind	Shares	Change	Value
AQR CAPITAL MANAGEMENT LLC	Hedge fund	1,102,131	+827,199	$16.7M
JPMORGAN CHASE & CO	Active fund	1,671,082	+740,916	$25.9M
BANK OF AMERICA CORP /DE/	Active fund	762,724	+592,711	$11.6M
Point72 Asset Management, L.P.	Hedge fund	803,120	−558,271	$12.2M

Identity

CIK: 0001645113
FIGI: BBG009XW8PY2
SIC: 3841 · Surgical & Medical Instruments & Apparatus
Headquarters: ST. HELIER

Ownership

Institutional: 90.6%
Institutions: 309
Insiders: 10.0%

Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.

Other surgical & medical instruments & apparatus companies

NovoCure Ltd files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.

BECTON DICKINSON & COBDX STRYKER CORPSYK BOSTON SCIENTIFIC CORPBSX Medline Inc.MDLN 3M COMMM BAXTER INTERNATIONAL INCBAX

Questions about NovoCure Ltd

How many subsidiaries does NovoCure Ltd file with the SEC?: 19, listed in its most recent exhibit 21. They are incorporated across 17 jurisdictions, led by Austria, Belgium, Canada. 2 of them sit in offshore financial centres. That exhibit is filed with the company's annual report and is the company's own list, not an estimate.
Is NovoCure Ltd financially healthy?: NovoCure Ltd scores 3 out of 9 on the Piotroski F-score. Its Altman Z-score puts it in the distress zone. Every test and the numbers behind it are shown above, so the arithmetic is checkable rather than something you have to take on trust.
Who are the largest institutional holders of NovoCure Ltd?: Among the managers tracked here, the biggest positions as of the 2026-Q2 13F filings are FMR LLC (adding), BlackRock, Inc. (adding), MORGAN STANLEY (trimming). Direction is the change in share count against that manager's own previous filing; managers with no prior filing are left out rather than counted as new buyers.

This page is one panel of the terminal

The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.

Download the terminal See pricing

Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.